AX-2026-042325 · Kisspeptin-10 · TFC lot TFC-2604-B2419

Section 1

Results

Measured against the index acceptance specification for the melanocortin-receptor peptides class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.

Parameter	Method	Result	Unit	Index spec
Purity	RP-HPLC, 35 min gradient, 214 nm	99.63	% area	≥ 98.5	PASS
Total impurities	RP-HPLC, sum of reported peaks	0.37	% area	≤ 1.5	PASS
Largest single impurity	RP-HPLC — oxidised Trp (+16 Da)	0.18	% area	≤ 1.00	PASS
Identity — theoretical monoisotopic mass	calculated from molecular formula	1301.6300	Da	—	NOT TESTED
Identity — observed monoisotopic mass	LC-MS, high resolution (ESI-TOF/QTOF)	1301.6312	Da	—	NOT TESTED
Mass accuracy	observed vs theoretical	+0.9	ppm	± 15	PASS
Total peptide content	by difference from the gravimetric mass balance	91.30	%w/w	—	NOT TESTED
Target-compound content	total peptide content × purity	90.96	%w/w	—	NOT TESTED
Gross fill (as weighed)	five-place balance, under nitrogen	10.01	mg	10 mg declared	NOT TESTED
Recovered target peptide	gross fill × target content	9.105	mg	10 mg claim	NOT TESTED
Recovery against label claim	recovered ÷ claim	91.1	%	90.0 – 110.0	PASS
Water content	Karl Fischer, coulometric, duplicate	4.98	%	≤ 8.0	PASS
Counter-ion (acetate)	anion-exchange ion chromatography	2.77	%	≤ 10.0	PASS
Residual solvent + inorganic residue	estimated — see /methods/residual-solvents-q3c/	0.95	%	—	NOT TESTED
Endotoxin	not ordered on this submission	not determined	—	≤ 5.0	NOT TESTED
Sterility	not ordered on this submission	not determined	—	no growth	NOT TESTED
Appearance	visual, diffuse light, black and white background	White cake, partial shrinkage from vial wall	—	white to off-white intact cake	FAIL
Reconstitution clarity	reconstituted per submitter procedure	Clear, colourless, no visible particulates	—	clear, no visible particulates	PASS
pH (reconstituted, 1 mg/mL)	potentiometric, two-point calibration	5.42	—	2.5 – 8.0	PASS
Retention time (observed)	RP-HPLC, 35 min gradient	11.22	min	10.54 ± 0.25 (normalised)	FAIL
Peak asymmetry (10 % height)	Ph. Eur. 2.2.46	0.86	—	0.80 – 1.50	PASS
Plate count, main peak	N = 5.54 (t/w½)²	84,456	—	≥ 20,000	PASS
Resolution to nearest impurity	vs [D-Trp]-epimer	0.88	—	no index criterion	REPORTED

Section 2

Chromatogram and peak integration

The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.

Figure 1. RP-HPLC trace, 35 min gradient, 214 nm. Drawn from the peak-integration table below: peak positions are the reported retention times, peak areas are the reported area percentages, peak widths follow the reported plate count of 84,456, and skew follows the reported asymmetry factor of 0.86. Baseline noise is seeded from the report ID and is illustrative. The lower panel is the same trace at a stated vertical expansion with the slow gradient drift subtracted, because at full scale a 0.18 % impurity against a 99.63 % main peak is a line two pixels tall; the main peak runs off-scale there by design.

#	Peak	RT	Area (µV·s)	% area	Δ mass (Da)
1	Kisspeptin-10 — main peak	11.22	4,842,327	99.63	—
2	oxidised Trp (+16 Da)	10.82	8,749	0.18	+15.995
3	des-Tyr (−163 Da)	10.57	5,346	0.11	-163.063
4	C-terminal free acid (+1 Da)	11.43	1,944	0.04	+0.984
5	[D-Trp]-epimer	11.08	1,944	0.04	0.000
Closure check — purity + Σ impurities				100.00	CLOSES

Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.

Section 3

Mass spectrum and identity

Theoretical monoisotopic mass 1301.6300 Da, computed from C63H83N17O14. All ppm figures on this site are against monoisotopic values — see why that matters.

Figure 2. ESI charge-state envelope, high-resolution instrument. Sticks are placed at m/z = (M + z × 1.007276)/z for the observed neutral mass of 1301.6312 Da. Sodium (+21.982/z) and potassium (+37.956/z) adducts are shown where the parent charge state exceeds 25 % relative abundance; they are adducts of the same molecule and are not impurities.

Charge	Theoretical m/z	Observed m/z	Δ m/z	Rel. abundance (%)
3+	434.8839	434.8843	0.0004	7.9
2+	651.8223	651.8229	0.0006	57.6
1+	1302.6373	1302.6385	0.0012	100.0

Section 4

Gravimetric mass balance

Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.

Component	Determination	%w/w of cake
Water	Karl Fischer	4.98
Counter-ion (acetate)	ion chromatography	2.77
Residual solvent + inorganic residue	estimated	0.95
Total peptide content	by difference	91.30
Total		100.00 CLOSES

Supplier certificate, as declared

The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.

Figure	Supplier COA	This report	Index note
Purity (% area)	99.25	99.63	divergence +0.01 pp vs batch median
Total impurities (% area)	not stated	0.37
Largest single impurity (% area)	not stated	0.18
Water (%)	4.6	4.98
Counter-ion (%)	not stated	2.77
Peptide content (%w/w)	96.2	91.30
Endotoxin (EU/mg)	not stated	not determined
Method stated on certificate	YES	—	column, gradient and wavelength given

Section 5

Provenance and caveats

Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.

Sample provenance: Buyer-sourced
Evidentiary weight: Strongest available evidence in this index.
Chain of custody: Retail purchase → submitter (ambient, 16 d) → laboratory (hand-carried, 2 d) → assay.
Assay date: 21 Jun 2026
Submitted to the index: 28 Jun 2026
Laboratory: Nordanalyt Laboratories, Uppsala, Sweden
Method basis: 35 min gradient · high-resolution MS
Verification status: VERIFIED

What this report does not establish

That the material is free of bacterial endotoxin. Endotoxin was not measured. No chromatographic result bears on it.
That the material is sterile. Sterility was not tested.
That any other vial in the same lot has the same composition. One vial was tested. Within-lot vial-to-vial variation in this index has a median of 0.28 pp and a 90th percentile of 0.74 pp.
That any other lot from the same supplier has the same composition. Batch-to-batch variation is larger than within-batch variation for every supplier here.
That the material is suitable for administration to a human or an animal. These are research compounds. No result on this site is a safety assessment and the index takes no position on use.
That the material was manufactured by the supplier that sold it. Contract synthesis is normal in this market and twenty-nine batches in the index fingerprint to a bulk from a different company than the one named on the label.

Section 6

Annotations 3

Signed technical comments from index contributors. Not a discussion forum — annotations question or contextualise the result, and the data team replies where a reply is warranted.

wide_iqr28 Jun 2026

A single result at 99.63 % is one draw. What makes a supplier's process legible is the spread across its lots, and that is on the scorecard rather than here. This record is one good point in a distribution worth reading whole.

lot_traceability28 Jun 2026

A retail vial at 99.63 % is worth more evidentially than a selected vial at a higher figure. That is the whole argument for recording provenance at all.

shipping_temp28 Jun 2026

A data logger in the box would upgrade this record further. Custody is documented; temperature history is inferred, and inference is weaker than measurement.

Section 7

Related records

Same batch — lot TFC-2604-B2419 n=11

Report	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2026-042316	TFC-2604-B2419	PeptideMeter	2026-Q2	98.92	5.25	—	Buyer-sourced	0	PASS
AX-2026-042317	TFC-2604-B2419	Janoshik	2026-Q2	99.50	4.27	97.3	Buyer-sourced	0	PASS
AX-2026-042318	TFC-2604-B2419	Nordanalyt	2026-Q2	99.44	5.77	96.8	Buyer-sourced	0	PASS
AX-2026-042319	TFC-2604-B2419	Janoshik	2026-Q2	99.19	5.09	—	Buyer-sourced	0	PASS
AX-2026-042320	TFC-2604-B2419	PeptideMeter	2026-Q2	98.90	4.70	103.2	Buyer-sourced	0	PASS
AX-2026-042321	TFC-2604-B2419	Janoshik	2026-Q2	99.51	4.63	90.1	Buyer-sourced	0	PASS
AX-2026-042322	TFC-2604-B2419	Medutest	2026-Q2	99.04	4.34	—	Buyer-sourced	0	PASS
AX-2026-042323	TFC-2604-B2419	PeptideMeter	2026-Q2	99.49	4.61	89.6	Buyer-sourced	1	MARGINAL
AX-2026-042324	TFC-2604-B2419	Janoshik	2026-Q2	99.22	5.23	105.6	Buyer-sourced	0	PASS
AX-2026-042326	TFC-2604-B2419	Janoshik	2026-Q2	99.24	5.74	103.7	Buyer-sourced	0	PASS

Batch rollup and reproducibility assessment →

Cross-sections

Other recent Kisspeptin-10 records in the index.
Report	Supplier	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2026-043179	GL Biochem	GLBI-2608-N7715	Medutest	2026-Q3	98.97	4.37	—	Buyer-sourced	1	MARGINAL
AX-2026-043178	GL Biochem	GLBI-2608-N7715	Janoshik	2026-Q3	98.50	4.55	—	Buyer-sourced	1	MARGINAL
AX-2026-043184	GL Biochem	GLBI-2608-N7715	Janoshik	2026-Q3	98.99	3.63	100.6	Supplier-supplied	1	MARGINAL
AX-2026-043185	GL Biochem	GLBI-2608-N7715	Medutest	2026-Q3	98.71	3.71	107.0	Buyer-sourced	1	MARGINAL
AX-2026-043182	GL Biochem	GLBI-2608-N7715	Janoshik	2026-Q3	98.93	3.86	95.7	Buyer-sourced	1	MARGINAL
AX-2026-043183	GL Biochem	GLBI-2608-N7715	PeptideMeter	2026-Q3	98.54	4.17	102.2	Buyer-sourced	1	MARGINAL
AX-2026-043186	GL Biochem	GLBI-2608-N7715	Janoshik	2026-Q3	98.56	3.60	96.8	Buyer-sourced	1	MARGINAL
AX-2026-043181	GL Biochem	GLBI-2608-N7715	Janoshik	2026-Q3	98.77	4.06	95.2	Buyer-sourced	1	MARGINAL

Other recent TFC records in the index.
Report	Compound	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2026-042265	Humanin (HNG)	TFC-2605-U1300	PeptideMeter	2026-Q3	99.52	6.31	—	Buyer-sourced	0	PASS
AX-2026-042222	SS-31 (Elamipretide)	TFC-2607-R9099	VendorInvestigate	2026-Q3	99.46	5.41	102.6	Buyer-sourced	0	PASS
AX-2026-042236	Humanin (HNG)	TFC-2608-S9940	Nordanalyt	2026-Q3	98.64	1.80	—	Buyer-sourced	0	PASS
AX-2026-042282	Retatrutide	TFC-2608-J1156	Janoshik	2026-Q3	98.54	4.27	—	Buyer-sourced	0	PASS
AX-2026-042226	SS-31 (Elamipretide)	TFC-2607-R9099	Janoshik	2026-Q3	99.62	5.47	—	Buyer-sourced	0	PASS
AX-2026-042217	Semaglutide	TFC-2604-X9037	PeptideMeter	2026-Q3	98.95	4.61	96.9	Buyer-sourced	0	PASS
AX-2026-042339	Sermorelin	TFC-2605-Y2176	Kestrel	2026-Q3	99.93	4.14	—	Supplier-supplied	1	FAIL
AX-2026-042214	Semaglutide	TFC-2604-X9037	Kestrel	2026-Q3	99.87	4.66	103.1	Laboratory-retained	0	PASS